News and Trends 25 Jan 2017 Genetically Engineered Mosquitoes will arrive in India to fight Dengue …engineers mosquitoes to reduce their populations in areas where they spread infectious diseases. After success in Brazil and the Cayman Islands, the company is now heading to India to fight… January 25, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Nov 2017 Austrian Biotech’s Vaccine Against Tropical Virus Moves Nicely Through Phase II …diseases, which have the potential to be the next global outbreak. The company has announced encouraging preliminary Phase II results for its vaccine against chikungunya fever. Next, Themis will hope… November 6, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 6 Nov 2018 First Potential Vaccine for Chikungunya Virus Flies Through Phase II …“Countries like Austria, France and Croatia can have outbreaks now.” Furthermore, as globalization and climate change trends continue, Tauber told me that we will need more treatments for tropical diseases… November 6, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2025 How are biotechs tackling malaria? …needed most.” Bringing affordable vaccines to the public: can MMV, Eyam Biotech, and GSK keep their promises? As malaria is one of the deadliest diseases, particularly among children, affordable ways… September 3, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2016 SynBio reinvents Photosynthesis with artificial CO2-fixing Pathway …of a metabolic pathway for fixing CO2, which is 20% more efficient than in plants. As described in an article just published in Science, a German research team has shown… November 28, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Jul 2025 Biotech stars of 2024, did they shine or fade in 2025? …partnership with Novo Nordisk expanded further, with a new program in metabolic dysfunction-associated steatohepatitis (MASH). Kriya Therapeutics also transitioned key programs into the clinic, including KRIYA‑825, a gene therapy for… July 23, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Oct 2025 Top biotech deals in September 2025 …Among the most advanced is the injectable GLP-1 MET-097i. Swiss pharma giant Roche took over California-based metabolic disease therapeutics company 89bio for $7.3 billion. Roche will nab 89bio’s metabolic dysfunction-associated… October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Sep 2022 Innovent starts trial of mazdutide in Chinese adults with obesity …was met. At week 24, each dose of mazdutide showed significant efficacy on body weight loss compared with placebo in a dose-dependent manner and brought multiple cardio-metabolic benefits to participants…. September 6, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 4 Nov 2022 Optibrium and Lhasa Limited study published on predictive modelling for enzymes …will underpin the development of new capabilities for technology platform StarDrop, enabling users to better determine the metabolic fate of drug candidates and further streamline the preclinical drug discovery process…. November 4, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 8 Apr 2022 Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by the Edinburgh-based Kynos Therapeutics, which aims to develop anti-inflammatory treatments by blocking an emerging metabolic… April 8, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2022 InfanDx tackles early detection of hypoxic ischemic encephalopathy InfanDx AG, a privately held diagnostics company focusing on the development and commercialization of novel diagnostic solutions for newborns, has completed the validation of metabolic biomarker panels for the early… November 14, 2022 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Weekly Roundup 8 Dec 2023 Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer …B funding round. The company is focused on addressing diseases driven by the expression of bacterial genes from the microbiome, and the money raised will go towards accelerating the development… December 8, 2023 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email